Divi’s Laboratories has reported results for second quarter ended September 30, 2019.
The company has reported a fall of 11.27% in its net profit at Rs 352.83 crore for the quarter under review as compared to Rs 397.65 crore for the same quarter in the previous year. However, total income of the company increased by 6.32% at Rs 1,451.28 crore for Q2FY20 as compared Rs 1,365.05 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 11.63% in its net profit at Rs 356.78 crore for the quarter under review as compared to Rs 403.72 crore for the same quarter in the previous year. However, total income of the company increased by 6.28% at Rs 1,492.60 crore for Q2FY20 as compared Rs 1,404.36 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1508.00 |
Dr. Reddys Lab | 6288.40 |
Cipla | 1414.75 |
Zydus Lifesciences | 953.15 |
Lupin | 1620.30 |
View more.. |